{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:13:18Z","timestamp":1788585198783,"version":"build-2803163510"},"reference-count":57,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s501560","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T05:00:11Z","timestamp":1735275611000},"page":"2637-2649","source":"Crossref","is-referenced-by-count":8,"title":["A Clinically Oriented Review of New Antipsychotics for Schizophrenia"],"prefix":"10.2147","volume":"Volume 20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5935-8283","authenticated-orcid":true,"given":"Maria","family":"Luca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-3759","authenticated-orcid":true,"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/med.22042","volume":"44","author":"Dudzik","year":"2024","journal-title":"Med Res Rev"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/ijnp\/pyad011","volume":"26","author":"Kantrowitz","year":"2023","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.2174\/1568026616666160608084834","volume":"16","author":"Li","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/TCRM.S117321","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/YIC.0000000000000523","volume":"39","author":"Serretti","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/YIC.0000000000000442","volume":"38","author":"Masumo","year":"2023","journal-title":"Int Clin Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000559","author":"Ricci","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","volume":"209","author":"Siskind","year":"2016","journal-title":"Br J Psychiatry"},{"key":"ref9","first-page":"55","volume":"53","author":"Naguy","year":"2023","journal-title":"Psychopharmacol Bull"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4088\/JCP.13049su1c.04","volume":"75","author":"Citrome","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.schres.2009.05.022","volume":"113","author":"Staring","year":"2009","journal-title":"Schizophr Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S109285291500070X","volume":"20","author":"Aquila","year":"2015","journal-title":"CNS Spectr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1192\/bjp.2021.61","volume":"220","author":"Siskind","year":"2022","journal-title":"Br J Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.biopsych.2024.05.014","volume":"96","author":"Howes","year":"2024","journal-title":"Biol Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.euroneuro.2019.06.008","volume":"29","author":"Corponi","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12916-017-0849-x","volume":"15","author":"Fernandes","year":"2017","journal-title":"BMC Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1590\/1516-4446-2021-1997","volume":"44","author":"Serretti","year":"2022","journal-title":"Braz J Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biopsych.2016.11.014","volume":"82","author":"Bugarski-Kirola","year":"2017","journal-title":"Biol Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/jpp\/rgae051","volume":"76","author":"de Carvalho","year":"2024","journal-title":"J Pharm Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jamapsychiatry.2014.163","volume":"71","author":"Umbricht","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12888-016-0778-9","volume":"16","author":"Hirayasu","year":"2016","journal-title":"BMC Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.euroneuro.2014.03.007","volume":"24","author":"Bugarski-Kirola","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S2215-0366(16)30344-3","volume":"3","author":"Bugarski-Kirola","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.clinthera.2012.08.010","volume":"34","author":"Hofmann","year":"2012","journal-title":"Clin Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pneurobio.2016.07.004","volume":"152","author":"Keshavan","year":"2017","journal-title":"Prog Neurobiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.mp.4001924","volume":"12","author":"Raedler","year":"2007","journal-title":"Mol Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/npp.2015.189","volume":"41","author":"Ghoshal","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00213-023-06362-2","volume":"240","author":"Breier","year":"2023","journal-title":"Psychopharmacology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa2017015","volume":"384","author":"Brannan","year":"2021","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41398-022-02254-9","volume":"12","author":"Sauder","year":"2022","journal-title":"Transl Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21m14316","volume":"83","author":"Weiden","year":"2022","journal-title":"J Clin Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0140-6736(23)02190-6","volume":"403","author":"Kaul","year":"2024","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamapsychiatry.2024.0785","volume":"81","author":"Kaul","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.schres.2024.08.001","volume":"274","author":"Horan","year":"2024","journal-title":"Schizophr Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41537-022-00320-1","volume":"8","author":"Correll","year":"2022","journal-title":"Schizophrenia"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/d41573-024-00155-8","volume":"23","author":"Kingwell","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.schres.2012.07.029","volume":"141","author":"Meltzer","year":"2012","journal-title":"Schizophr Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"sgac006","DOI":"10.1093\/schizbullopen\/sgac006","volume":"3","author":"Bugarski-Kirola","year":"2022","journal-title":"Schizophr Bull Open"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S2215-0366(21)00386-2","volume":"9","author":"Bugarski-Kirola","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/JCP.0000000000001611","volume":"42","author":"Darwish","year":"2022","journal-title":"J Clin Psychopharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/0091270007299431","volume":"47","author":"Vanover","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"892199","DOI":"10.3389\/fpsyt.2022.892199","volume":"13","author":"Bugarski-Kirola","year":"2022","journal-title":"Front Psychiatry"},{"key":"ref43","unstructured":"Acadia pharmaceuticals announces top-line results from Phase 3 ADVANCE-2 trial of pimavanserin in negative symptoms of schizophrenia. Acadia Pharmaceuticals; 2024. Available from: https:\/\/acadia.com\/media\/news-releases\/acadia-pharmaceuticals-announces-top-line-results-from-phase-3-advance-2-trial-of-pimavanserin-in-negative-symptoms-of-schizophrenia\/. Accessed October 30, 2024."},{"key":"ref44","unstructured":"Minerva neurosciences receives complete response letter from FDA for new drug application for roluperidone for the treatment of negative symptoms in patients with Schizophrenia. Available from: https:\/\/ir.minervaneurosciences.com\/news-releases\/news-release-details\/minerva-neurosciences-receives-complete-response-letter-fda-new. Accessed October 30, 2024."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1056\/NEJMoa1911772","volume":"382","author":"Koblan","year":"2020","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41537-021-00190-z","volume":"7","author":"Correll","year":"2021","journal-title":"NPJ Schizophr"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/cts.13512","volume":"16","author":"Tsukada","year":"2023","journal-title":"Clin Transl Sci"},{"key":"ref48","unstructured":"Sumitomo pharma and otsuka announce topline results from phase 3 DIAMOND 1 and DIAMOND 2 clinical studies evaluating ulotaront in schizophrenia. Available from: https:\/\/otsuka-us.com\/news\/sumitomo-pharma-and-otsuka-announce-topline-results-phase-3-diamond-1-and-diamond-2-clinical. Accessed October 30, 2024."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.33160\/yam.2018.06.001","volume":"61","author":"Kaneko","year":"2018","journal-title":"Yonago Acta Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/YIC.0000000000000538","volume":"39","author":"Abdel Aziz","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0006-3223(01)01271-9","volume":"50","author":"Conley","year":"2001","journal-title":"Biol Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/schbul\/sbi031","volume":"31","author":"Malla","year":"2005","journal-title":"Schizophr Bull"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-244X-12-20","volume":"12","author":"Dibonaventura","year":"2012","journal-title":"BMC Psychiatry"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00406-023-01576-z","volume":"273","author":"Rosenbrock","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"52","author":"Dirks","year":"2022","journal-title":"Psychopharmacol Bull"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/biomedicines12061263","volume":"12","author":"Shemiakova","year":"2024","journal-title":"Biomedicines"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e35614","DOI":"10.1097\/MD.0000000000035614","volume":"102","author":"Michelly Gon\u00e7alves Brand\u00e3o","year":"2023","journal-title":"Medicine"}],"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/98763","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/98763","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T05:00:17Z","timestamp":1735275617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/a-clinically-oriented-review-of-new-antipsychotics-for-schizophrenia-peer-reviewed-fulltext-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"URL":"https:\/\/doi.org\/10.2147\/ndt.s501560","relation":{},"ISSN":["1178-2021"],"issn-type":[{"value":"1178-2021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}